Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1636303
PUBLISHER: IMARC | PRODUCT CODE: 1636303
Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global neutropenia treatment market size reached USD 16.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24 Billion by 2033, exhibiting a growth rate (CAGR) of 4.7% during 2025-2033. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors driving the market.
Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast, and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells.
Neutropenia Treatment Market Trends:
The rising awareness of neutropenia and chemotherapy-related side effects is one of the key factors driving the market growth. In line with this, the increasing demand for oral drugs that are available in capsule and tablet form and consist of convenient routes of administration is favoring the market growth. Moreover, key players are actively engaged in disseminating relevant information and knowledge regarding preventive measures, early diagnosis, and effective treatment of neutropenia, which, in turn, is propelling the market growth. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is acting as another growth-inducing factor. In addition to this, manufacturers are focusing on the introduction of cost-effective medicines for neutropenia treatment, which is facilitating the market growth. Additionally, the utilization of novel drug delivery methods that helps in improving patient convenience, which leads to improved patient adherence, is positively influencing the market growth. Besides this, the increase in febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars are creating a positive outlook for the market. The market is also driven by the easy availability of medications through online retail portals, such as registered websites, which provides convenience of ordering and procurement of medications at affordable price-points. Other factors, including extensive research and development (R&D) activities, the introduction of innovative and effective drugs, rising incidences of cancer, easy access to healthcare facilities owing to improved infrastructure, increasing expenditure capacities of consumers and the implementation of various government initiatives for promoting public health, are anticipated to drive the market growth.
Key Market Segmentation:
Treatment Insights:
- Colony-Stimulating Factors
- Antibiotics
- Antifungals
- Antivirals
Distribution channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global neutropenia treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amgen Inc., BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited), Pfizer Inc., Sandoz Inc. (Novartis AG), Spectrum Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. How big is the global neutropenia treatment market?
- 2. What is the expected growth rate of the global neutropenia treatment market during 2025-2033?
- 3. What are the key factors driving the global neutropenia treatment market?
- 4. What has been the impact of COVID-19 on the global neutropenia treatment market?
- 5. What is the breakup of the global neutropenia treatment market based on the treatment?
- 6. What is the breakup of the global neutropenia treatment market based on the distribution channel?
- 7. What are the key regions in the global neutropenia treatment market?
- 8. Who are the key players/companies in the global neutropenia treatment market?
Product Code: SR112025A6852
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Neutropenia Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Treatment
- 6.1 Colony-Stimulating Factors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Antibiotics
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Antifungals
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Antivirals
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Distribution Channel
- 7.1 Hospital Pharmacies
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Retail Pharmacies
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Online Pharmacies
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
- 9.1 Overview
- 9.2 Drivers
- 9.3 Restraints
- 9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Amgen Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 BeyondSpring Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.3 Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Pfizer Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Sandoz Inc. (Novartis AG)
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 SWOT Analysis
- 13.3.6 Spectrum Pharmaceuticals Inc.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Teva Pharmaceutical Industries Ltd.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Viatris Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.1 Amgen Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Product Code: SR112025A6852
List of Figures
- Figure 1: Global: Neutropenia Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Neutropenia Treatment Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Neutropenia Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Neutropenia Treatment Market: Breakup by Treatment (in %), 2024
- Figure 5: Global: Neutropenia Treatment Market: Breakup by Distribution Channel (in %), 2024
- Figure 6: Global: Neutropenia Treatment Market: Breakup by Region (in %), 2024
- Figure 7: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 8: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 9: Global: Neutropenia Treatment (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Neutropenia Treatment (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Neutropenia Treatment (Antifungals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Neutropenia Treatment (Antifungals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Neutropenia Treatment (Antivirals) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Neutropenia Treatment (Antivirals) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Neutropenia Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Neutropenia Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Neutropenia Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Neutropenia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Neutropenia Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Neutropenia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: North America: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: North America: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: United States: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: United States: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Canada: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Canada: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Asia-Pacific: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Asia-Pacific: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: China: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: China: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Japan: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Japan: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: India: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: India: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: South Korea: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: South Korea: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: Australia: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: Australia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Indonesia: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Indonesia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: Europe: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: Europe: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Germany: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Germany: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: France: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: France: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: United Kingdom: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: United Kingdom: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Italy: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Italy: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: Spain: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: Spain: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: Russia: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: Russia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Latin America: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Latin America: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Brazil: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Brazil: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Mexico: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Mexico: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: Middle East and Africa: Neutropenia Treatment Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: Middle East and Africa: Neutropenia Treatment Market: Breakup by Country (in %), 2024
- Figure 69: Middle East and Africa: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Global: Neutropenia Treatment Industry: Drivers, Restraints, and Opportunities
- Figure 71: Global: Neutropenia Treatment Industry: Value Chain Analysis
- Figure 72: Global: Neutropenia Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Neutropenia Treatment Market: Key Industry Highlights, 2024 & 2033
- Table 2: Global: Neutropenia Treatment Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
- Table 3: Global: Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 4: Global: Neutropenia Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 5: Global: Neutropenia Treatment Market: Competitive Structure
- Table 6: Global: Neutropenia Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.